Tokyo Electric Power Company Holdings, Incorporated
TKECY News Today: Stay Updated with the Latest Tokyo Electric Power Company Holdings, Incorporated News in Real Time
Find TKECY news now at Meyka AI. Stay informed with the latest Tokyo Electric Power Company Holdings, Incorporated stocks updates, including price news, market analysis, and expert insights.
Simon Dutton Arrested May 15: UK Most Wanted Drug Trafficker Caught
Simon Dutton, 49, arrested in Spain for cocaine importation, money laundering, and false passport offences—major breakthrough in UK fugitive manhunt.
HOD.TO Stock Slides 1.9% as Crude Oil Inverse ETF Faces Headwinds
HOD.TO stock drops 1.9% to C$1.04 on May 14. BetaPro Crude Oil Inverse Leveraged Daily Bear ETF faces pressure amid market volatility.
Briscoe Group Limited (BGP.AX) Holds A$3.64 as Retail Headwinds Persist
BGP.AX stock flat at A$3.64 amid consumer cyclical sector weakness. Meyka AI rates B+ with neutral outlook.
ENNVU Stock Bounces 7.2% as Blank Check Company Seeks Merger Target
ENNVU stock surges 7.2% to $7.93 on oversold bounce. ECP Environmental Growth Opportunities Corp. seeks acquisition target.
CBRS Stock May 15: AI Chip Maker Debuts Amid Valuation Caution
Cerebras IPO May 15: AI chip maker CBRS debuts at $185, challenging Nvidia. Jim Cramer cautions on valuation as stock surges on AI demand.
APEMY: Deutsche Bank Maintains Buy Rating, May 2026
Deutsche Bank maintains Buy rating on APEMY, raising price target to EUR 63 from EUR 62. Stock trades at $55.40.
Open Orphan Plc (ORPH.IR) Holds Steady at €0.14 on EURONEXT
ORPH.IR stock trades flat at €0.14 on EURONEXT. Biotech firm specializes in human challenge trials and infectious disease research.
Addex Therapeutics (ADXN.SW) Jumps 6.7% as CNS Drug Pipeline Advances
ADXN.SW stock surges 6.7% to CHF 0.048 on SIX. Addex Therapeutics advances CNS drug programs including Dipraglurant and ADX71149.
Aqualine Ltd. (6173.T) Plummets 32% as Water Services Firm Faces Profitability Crisis
Aqualine Ltd. (6173.T) stock crashes 32% on JPX amid mounting losses and weak fundamentals. Meyka AI rates the stock D+.